Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II - PubMed (original) (raw)
doi: 10.1161/01.HYP.0000205833.89478.5b. Epub 2006 Feb 27.
Mitsuru Ohishi, Tomohiro Katsuya, Norihisa Ito, Masashi Ikushima, Masaharu Kaibe, Yuji Tatara, Atsushi Shiota, Sumio Sugano, Satoshi Takeda, Hiromi Rakugi, Toshio Ogihara
Affiliations
- PMID: 16505206
- DOI: 10.1161/01.HYP.0000205833.89478.5b
Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II
Koichi Yamamoto et al. Hypertension. 2006 Apr.
Abstract
Angiotensin-converting enzyme 2 (ACE2) is a carboxypeptidase that cleaves angiotensin II to angiotensin 1-7. Recently, it was reported that mice lacking ACE2 (ACE2(-/y) mice) exhibited reduced cardiac contractility. Because mechanical pressure overload activates the cardiac renin-angiotensin system, we used ACE2(-/y) mice to analyze the role of ACE2 in the response to pressure overload. Twelve-week-old ACE2(-/y) mice and wild-type (WT) mice received transverse aortic constriction (TAC) or sham operation. Sham-operated ACE2(-/y) mice exhibited normal cardiac function and had morphologically normal hearts. In response to TAC, ACE2(-/y) mice developed cardiac hypertrophy and dilatation. Furthermore, their hearts displayed decreased cardiac contractility and increased fetal cardiac gene induction, compared with WT mice. In response to chronic pressure overload, ACE2(-/y) mice developed pulmonary congestion and increased incidence of cardiac death compared with WT mice. On a biochemical level, cardiac angiotensin II concentration and activity of mitogen-activated protein (MAP) kinases were markedly increased in ACE2(-/y) mice in response to TAC. Administration of candesartan, an AT1 subtype angiotensin receptor blocker, attenuated the hypertrophic response and suppressed the activation of MAP kinases in ACE2(-/y) mice. Activation of MAP kinases in response to angiotensin II was greater in cardiomyocytes isolated from ACE2(-/y) mice than in those isolated from WT mice. ACE2 plays an important role in dampening the hypertrophic response to pressure overload mediated by angiotensin II. Disruption of this regulatory function may accelerate cardiac hypertrophy and shorten the transition period from compensated hypertrophy to cardiac failure.
Similar articles
- The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X, Ye Y, Gong H, Wu J, Yuan J, Wang S, Yin P, Ding Z, Kang L, Jiang Q, Zhang W, Li Y, Ge J, Zou Y. Wang X, et al. J Mol Cell Cardiol. 2016 Aug;97:180-90. doi: 10.1016/j.yjmcc.2016.05.012. Epub 2016 May 19. J Mol Cell Cardiol. 2016. PMID: 27210827 - Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
Nakamura K, Koibuchi N, Nishimatsu H, Higashikuni Y, Hirata Y, Kugiyama K, Nagai R, Sata M. Nakamura K, et al. Hypertens Res. 2008 Oct;31(10):1953-61. doi: 10.1291/hypres.31.1953. Hypertens Res. 2008. PMID: 19015603 - Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY. Zhong J, et al. Circulation. 2010 Aug 17;122(7):717-28, 18 p following 728. doi: 10.1161/CIRCULATIONAHA.110.955369. Epub 2010 Aug 2. Circulation. 2010. PMID: 20679547 - Role of the renin-angiotensin system in cardiac hypertrophy.
Yamazaki T, Komuro I, Yazaki Y. Yamazaki T, et al. Am J Cardiol. 1999 Jun 17;83(12A):53H-57H. doi: 10.1016/s0002-9149(99)00259-3. Am J Cardiol. 1999. PMID: 10750588 Review. - Diastolic dysfunction in pressure-overload hypertrophy and its modification by angiotensin II: current concepts.
Lorell BH. Lorell BH. Basic Res Cardiol. 1992;87 Suppl 2:163-72. doi: 10.1007/978-3-642-72477-0_14. Basic Res Cardiol. 1992. PMID: 1338563 Review.
Cited by
- Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
Khoury EE, Knaney Y, Fokra A, Kinaneh S, Azzam Z, Heyman SN, Abassi Z. Khoury EE, et al. J Cell Mol Med. 2021 Apr;25(8):3840-3855. doi: 10.1111/jcmm.16310. Epub 2021 Mar 4. J Cell Mol Med. 2021. PMID: 33660945 Free PMC article. - Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress.
Rabelo LA, Todiras M, Nunes-Souza V, Qadri F, Szijártó IA, Gollasch M, Penninger JM, Bader M, Santos RA, Alenina N. Rabelo LA, et al. PLoS One. 2016 Apr 12;11(4):e0150255. doi: 10.1371/journal.pone.0150255. eCollection 2016. PLoS One. 2016. PMID: 27070147 Free PMC article. - Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling.
Clarke NE, Fisher MJ, Porter KE, Lambert DW, Turner AJ. Clarke NE, et al. PLoS One. 2012;7(4):e34747. doi: 10.1371/journal.pone.0034747. Epub 2012 Apr 16. PLoS One. 2012. PMID: 22523556 Free PMC article. - In the eye of the storm: the right ventricle in COVID-19.
Park JF, Banerjee S, Umar S. Park JF, et al. Pulm Circ. 2020 Jul 2;10(3):2045894020936660. doi: 10.1177/2045894020936660. eCollection 2020 Jul-Sep. Pulm Circ. 2020. PMID: 32655856 Free PMC article. Review. - Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
Bodiga S, Zhong JC, Wang W, Basu R, Lo J, Liu GC, Guo D, Holland SM, Scholey JW, Penninger JM, Kassiri Z, Oudit GY. Bodiga S, et al. Cardiovasc Res. 2011 Jul 1;91(1):151-61. doi: 10.1093/cvr/cvr036. Epub 2011 Feb 1. Cardiovasc Res. 2011. PMID: 21285291 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials